Blockchain could revolutionise the way patients think about their clinical data, allowing them to control who uses it and receiving financial rewards for participating in trials.
Pierre Fabre Pharmaceuticals has joined a blockchain consortium that allows patients to share real-time digital health data to inform late-stage clinical research.
Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in distributed ledger technology (DLT) on the rise, then it would appear that momentum is b
Healthcare data is everywhere and more is coming – data from wearables, data from Internet of Things devices, genomic data, and ‘omics’ data more broadly.
Endeavor BioMedicines has completed a third-round financing, raising an impressive $132.5 million to fund trials of its two clinical-stage drug candidates for pulmonary fi
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.
